The University of Southampton
University of Southampton Institutional Repository

Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering

Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering
Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering
Rationale: Oral corticosteroids effectively treat asthma exacerbations but are associated with well-described side effects.

Objective: This study compared the efficacy and safety of a high dose of an inhaled corticosteroid with oral prednisolone in patients with worsening of their asthma after medication withdrawal.

Methods: Patients tapered off their inhaled corticosteroids until they reached predefined criteria of "worsening asthma". Randomized patients (n=130) were treated double blind with either ciclesonide 800?g twice daily (starting with 800?g hourly for 3h after randomization) or prednisolone 40mg once daily for 2 weeks. Spirometry, daily asthma symptoms, morning and evening peak expiratory flow and blood parameters were assessed in all, methacholine challenge and inflammatory measures were determined in induced sputum in a subset of patients.

Results: Ciclesonide was as effective as prednisolone in improving forced expiratory flow in 1s, morning peak expiratory flow and symptoms, the latter improving more rapidly with ciclesonide. No differences were found in methacholine responsiveness or inflammatory measures in sputum or blood. Ciclesonide caused significantly less reduction in morning plasma cortisol levels (p<0.0001).

Conclusion: This study shows that inhaled ciclesonide (800?g twice daily) has comparable efficacy to oral prednisolone (40mg once daily) to regain asthma control in patients with asthma worsening. The more rapid onset and smaller effect on cortisol suppression suggest a better safety profile of ciclesonide.
asthma, prednisolone, ciclesonide
1216-1223
van den Berge, M.
31c20943-1b86-4b02-818c-140b8980ccd3
Arshad, S.H.
917e246d-2e60-472f-8d30-94b01ef28958
Magnussen, H.
d745e23b-9e77-42b2-bdf8-18252730e1c1
Hamelmann, E.
85a0e5d2-f6c8-44f3-8d08-78437838a072
Kanniess, F.
b285f718-2b52-4b67-b32c-d20ffaa3e64b
Postma, D.S.
cbb4466d-4e7a-4c0f-b9df-7c19c4d31016
van den Berge, M.
31c20943-1b86-4b02-818c-140b8980ccd3
Arshad, S.H.
917e246d-2e60-472f-8d30-94b01ef28958
Magnussen, H.
d745e23b-9e77-42b2-bdf8-18252730e1c1
Hamelmann, E.
85a0e5d2-f6c8-44f3-8d08-78437838a072
Kanniess, F.
b285f718-2b52-4b67-b32c-d20ffaa3e64b
Postma, D.S.
cbb4466d-4e7a-4c0f-b9df-7c19c4d31016

van den Berge, M., Arshad, S.H., Magnussen, H., Hamelmann, E., Kanniess, F. and Postma, D.S. (2009) Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering. Respiratory Medicine, 103 (8), 1216-1223. (doi:10.1016/j.rmed.2009.01.024). (PMID:19297141)

Record type: Article

Abstract

Rationale: Oral corticosteroids effectively treat asthma exacerbations but are associated with well-described side effects.

Objective: This study compared the efficacy and safety of a high dose of an inhaled corticosteroid with oral prednisolone in patients with worsening of their asthma after medication withdrawal.

Methods: Patients tapered off their inhaled corticosteroids until they reached predefined criteria of "worsening asthma". Randomized patients (n=130) were treated double blind with either ciclesonide 800?g twice daily (starting with 800?g hourly for 3h after randomization) or prednisolone 40mg once daily for 2 weeks. Spirometry, daily asthma symptoms, morning and evening peak expiratory flow and blood parameters were assessed in all, methacholine challenge and inflammatory measures were determined in induced sputum in a subset of patients.

Results: Ciclesonide was as effective as prednisolone in improving forced expiratory flow in 1s, morning peak expiratory flow and symptoms, the latter improving more rapidly with ciclesonide. No differences were found in methacholine responsiveness or inflammatory measures in sputum or blood. Ciclesonide caused significantly less reduction in morning plasma cortisol levels (p<0.0001).

Conclusion: This study shows that inhaled ciclesonide (800?g twice daily) has comparable efficacy to oral prednisolone (40mg once daily) to regain asthma control in patients with asthma worsening. The more rapid onset and smaller effect on cortisol suppression suggest a better safety profile of ciclesonide.

This record has no associated files available for download.

More information

Published date: August 2009
Keywords: asthma, prednisolone, ciclesonide

Identifiers

Local EPrints ID: 145857
URI: http://eprints.soton.ac.uk/id/eprint/145857
PURE UUID: 2bc5f46a-726c-499f-9d98-dac67b7c406f

Catalogue record

Date deposited: 19 Apr 2010 15:42
Last modified: 14 Mar 2024 00:52

Export record

Altmetrics

Contributors

Author: M. van den Berge
Author: S.H. Arshad
Author: H. Magnussen
Author: E. Hamelmann
Author: F. Kanniess
Author: D.S. Postma

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×